Inhaltsbereich
| 218 Einträge | « ‹ 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 › » |
Seite 3 / 11
 Druckansicht
|
| Taxanes for ovarian cancer during pregnancy: a systematic review. |
| Zagouri F, Sergentanis TN, Chrysikos D, Filipits M, Bartsch R |
| Oncology. 2012 Aug 16. pii: 000341351. doi: 10.1159/000341351 |
| PMID: 22907101 |
| Influence of the American ODAC statement on Austrian bevacizumab prescribing practice for metastatic breast cancer. |
| Preusser M, Fülöp G, Berghoff AS, Heinzl H, Steger GG, Greil R, Zielinski CC, Bartsch R |
| The oncologist. 2012 Jun 27. pii: theoncologist.2012-0115. doi: 10.1634/theoncologist.2012-0115. pmc: PMC3399659 |
| PMID: 22744818 |
| Bisphosphonates in early breast cancer. |
| Dubsky P, Bartsch R |
| The Lancet. Oncology. 2012 Jun 14. pii: S1470-2045(12)70262-0. doi: 10.1016/S1470-2045(12)70262-0 |
| PMID: 22704582 |
| Molecularly targeted therapies in cervical cancer. A systematic review. |
| Zagouri F, Sergentanis TN, Chrysikos D, Filipits M, Bartsch R |
| Gynecologic oncology. 2012 Apr 11. pii: S0090-8258(12)00259-4. doi: 10.1016/j.ygyno.2012.04.007 |
| PMID: 22504292 |
| Axillary Dissection in the Case of Positive Sentinel Lymph Nodes: Results of the Innsbruck Consensus Conference. |
| Hubalek M, Bartsch R, Gnant M, Kapp KS, Lang A, Lax S, Lukas P, Neunteufel W, Pristauz G, Reitsamer R, Sandbichler P, Schrenk P, Singer C, Tamussino K, Tschmelitsch J, Zeimet AG, Marth C |
| Geburtshilfe und Frauenheilkunde. 2014 Oct 6. doi: 10.1055/s-0031-1298441. pmc: PMC4168401 |
| PMID: 25284834 |
| Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer. |
| Bartsch R, Bago-Horvath Z, Berghoff A, DeVries C, Pluschnig U, Dubsky P, Rudas M, Mader RM, Rottenfusser A, Fitzal F, Gnant M, Zielinski CC, Steger GG |
| European journal of cancer (Oxford, England : 1990). 2012 Mar 27. pii: S0959-8049(12)00247-X. doi: 10.1016/j.ejca.2012.03.002 |
| PMID: 22459763 |
| Trends and Novel Approaches in Neoadjuvant Treatment of Breast Cancer. |
| Steger GG, Bartsch R |
| Breast care (Basel, Switzerland). 2011 Dec 15. doi: 10.1159/000335331. pii: brc-0006-0427. pmc: PMC3290012 |
| PMID: 22419895 |
| Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group. |
| Dubsky PC, Jakesz R, Mlineritsch B, Pöstlberger S, Samonigg H, Kwasny W, Tausch C, Stöger H, Haider K, Fitzal F, Singer CF, Stierer M, Sevelda P, Luschin-Ebengreuth G, Taucher S, Rudas M, Bartsch R, Steger GG, Greil R, Filipcic L, Gnant M |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Jan 23. pii: JCO.2011.36.8993. doi: 10.1200/JCO.2011.36.8993 |
| PMID: 22271481 |
| Brain metastases free survival differs between breast cancer subtypes. |
| Berghoff A, Bago-Horvath Z, De Vries C, Dubsky P, Pluschnig U, Rudas M, Rottenfusser A, Knauer M, Eiter H, Fitzal F, Dieckmann K, Mader RM, Gnant M, Zielinski CC, Steger GG, Preusser M, Bartsch R |
| British journal of cancer. 2012 Jan 10. pii: bjc2011597. doi: 10.1038/bjc.2011.597. pmc: PMC3273356 |
| PMID: 22233926 |
| Brain metastases: pathobiology and emerging targeted therapies. |
| Preusser M, Capper D, Ilhan-Mutlu A, Berghoff AS, Birner P, Bartsch R, Marosi C, Zielinski C, Mehta MP, Winkler F, Wick W, von Deimling A |
| Acta neuropathologica. 2012 Jan 3. doi: 10.1007/s00401-011-0933-9 |
| PMID: 22212630 |
| Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases. |
| Bartsch R, Berghoff A, Pluschnig U, Bago-Horvath Z, Dubsky P, Rottenfusser A, DeVries C, Rudas M, Fitzal F, Dieckmann K, Mader RM, Gnant M, Zielinski CC, Steger GG |
| British journal of cancer. 2011 Nov 29. pii: bjc2011531. doi: 10.1038/bjc.2011.531. pmc: PMC3251869 |
| PMID: 22127284 |
| Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer. |
| Bago-Horvath Z, Rudas M, Dubsky P, Jakesz R, Singer CF, Kemmerling R, Greil R, Jelen A, Böhm G, Jasarevic Z, Haid A, Gruber C, Pöstlberger S, Filipits M, Gnant M |
| Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Oct 13. pii: 1078-0432.CCR-11-1846. doi: 10.1158/1078-0432.CCR-11-1846 |
| PMID: 21998336 |
| Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion. |
| Steger GG, Bartsch R |
| Therapeutic advances in medical oncology. 2011 Sep 29. doi: 10.1177/1758834011412656. pii: 10.1177_1758834011412656. pmc: PMC3169928 |
| PMID: 21957430 |
| A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. |
| Filipits M, Rudas M, Jakesz R, Dubsky P, Fitzal F, Singer CF, Dietze O, Greil R, Jelen A, Sevelda P, Freibauer C, Müller V, Jänicke F, Schmidt M, Kölbl H, Rody A, Kaufmann M, Schroth W, Brauch H, Schwab M, Fritz P, Weber KE, Feder IS, Hennig G, Kronenwett R, Gehrmann M, Gnant M |
| Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Aug 1. pii: 1078-0432.CCR-11-0926. doi: 10.1158/1078-0432.CCR-11-0926 |
| PMID: 21807638 |
| Neoadjuvant chemotherapy increases the rate of breast conservation in lobular-type breast cancer patients. |
| Fitzal F, Mittlboeck M, Steger G, Bartsch R, Rudas M, Dubsky P, Riedl O, Jakesz R, Gnant M |
| Annals of surgical oncology. 2011 Jul 9. doi: 10.1245/s10434-011-1879-9 |
| PMID: 21743980 |
| Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value. |
| Michlmayr A, Bachleitner-Hofmann T, Baumann S, Marchetti-Deschmann M, Rech-Weichselbraun I, Burghuber C, Pluschnig U, Bartsch R, Graf A, Greil R, Allmaier G, Steger G, Gnant M, Bergmann M, Oehler R |
| British journal of cancer. 2010 Sep 28. pii: 6605909. doi: 10.1038/sj.bjc.6605909. pmc: PMC2967072 |
| PMID: 20877360 |
| Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study. |
| Fitzal F, Riedl O, Mittlböck M, Dubsky P, Bartsch R, Steger G, Jakesz R, Gnant M |
| Breast cancer research and treatment. 2010 Sep 17. doi: 10.1007/s10549-010-1164-9 |
| PMID: 20848185 |
| Triple-negative breast cancer. |
| Bartsch R, Ziebermayr R, Zielinski CC, Steger GG |
| Wiener medizinische Wochenschrift (1946). 2010 May 17. doi: 10.1007/s10354-010-0773-6 |
| PMID: 20473728 |
| Attitudes towards palliative care in primary metastatic cancer: a survey among oncologists. |
| Kierner KA, Gartner V, Bartsch R, Hladschik-Kermer B, Gruber A, Hassler M, Watzke HH |
| Wiener klinische Wochenschrift. 2010 Feb 23. doi: 10.1007/s00508-009-1295-3 |
| PMID: 20177859 |
| A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study. |
| Wiedermann U, Wiltschke C, Jasinska J, Kundi M, Zurbriggen R, Garner-Spitzer E, Bartsch R, Steger G, Pehamberger H, Scheiner O, Zielinski CC |
| Breast cancer research and treatment. 2010 Jan 19. |
| PMID: 20092022 |
| 218 Einträge | « ‹ 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 › » |
Seite 3 / 11
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
